1 active not recruiting. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Active not recruiting 1 |
Follow Urethral Neoplasms: new trials by email Literature Review of Urethral Neoplasms trials Research Report on Urethral Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery Durvalumab, Therapeutic Conventional Surgery, Tremelimumab - Hydronephrosis, Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant | Early Phase 1 | Active not recruiting | M.D. Anderson Cancer Center | 54 | 2017-03-07 | 2026-09-14 |
Hydronephrosis (1) · Ureteral Neoplasms (1)
Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Ureteral Diseases (1) · Urethral Diseases (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1) · Urologic Diseases (1) · Urologic Neoplasms (1)
Disulfides (1) · Immunoglobulin G (1) · durvalumab (1) · tremelimumab (1)
M.D. Anderson Cancer Center (1)
United States (1)
Jianjun Gao (1)
P30CA016672 (1)